The methicillin-resistant Staphylococcus aureus (MRSA) therapeutics market across the seven major markets (7MM) is expected to grow to $1.8b in 2034 from $1.3b in 2024, according to GlobalData.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results